newsfilter
← Latest News
GlobeNewswire·

Longeveron Adds Seasoned Biotech Executive Todd Girolamo to Its Board of Directors

MIAMI, Feb. 17, 2022 (GLOBE NEWSWIRE) -- Longeveron Inc. (NASDAQ:LGVN) ("Longeveron" or "Company"), a clinical stage biotechnology company developing cellular therapies for chronic, aging-related and life-threatening conditions, announced today the ap